Navigation Links
One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
Date:9/21/2007

appetite, the amount of food eaten, and body weight. These are not all the side effects with BYETTA. A healthcare provider should be consulted about any side effect that is bothersome or does not go away.

For complete safety profile and other important prescribing considerations, visit http://www.BYETTA.com.

About Amylin and Lilly

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first- in-class medicines for diabetes. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is located in San Diego, California with over 1,700 employees nationwide.

Through a long-standing commitment to diabetes care, Lilly provides patients with breakthrough treatments that enable them to live longer, healthier and fuller lives. Since 1923, Lilly has been the industry leader in pioneering therapies to help health care professionals improve the lives of people with diabetes, and research continues on innovative medicines to address the unmet needs of patients.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Indiana, Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs.

This press release contains forward-looking statements about Amylin and Lilly. Actual results could differ materially from those discussed or implied in this press release due to a number of risks and uncertainties, including the risk that exenatide and the revenu
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 2014 /CNW/ - Health Minister Rona Ambrose today ... for donation over $2.5 million in personal protective equipment (PPE) ... global response to the Ebola outbreak in West ... shortage of equipment in the affected countries and has appealed ... in the affected countries. Personal protective equipment ...
(Date:9/15/2014)... , Sept. 15, 2014 /PRNewswire/ -  Pivotal Therapeutics ... specialty pharmaceutical company with a focus on Omega-3 ... today that the Board of Directors approved the ... an advisor at the close of business on Friday, ... of 1,000,000 common shares of the Company were ...
(Date:9/15/2014)... DALLAS , Sept. 15, 2014 /PRNewswire-iReach/ -- ... affects persons of all ages, but most commonly ... condition characterized by narrowing of the airways, leading ... the lungs come into contact with endogenous and ... of events, such as swelling of the airways, ...
Breaking Medicine Technology:Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 2Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 3Pivotal Therapeutics Grants Incentive Stock Options 2Asthma Market to Reach 161.02 million Cases in 10MM by 2023 2Asthma Market to Reach 161.02 million Cases in 10MM by 2023 3Asthma Market to Reach 161.02 million Cases in 10MM by 2023 4Asthma Market to Reach 161.02 million Cases in 10MM by 2023 5
... 1, 2011 Deb Group today announced the ... the world,s first group monitoring system to report ... new innovation, hospitals can now immediately monitor compliance ... "Five Moments for Hand Hygiene." A stand-alone system, ...
... Echo Therapeutics, Inc. (OTC Bulletin Board: ... tCGM System as a non-invasive, wireless, transdermal continuous ... System for transdermal drug delivery, today announced that ... & Sullivan Technology Innovation Award in Pharmaceuticals and ...
Cached Medicine Technology:Deb Group Introduces First Real-time Hand Hygiene Group Monitoring System Based on World Health Organization Guidelines 2Deb Group Introduces First Real-time Hand Hygiene Group Monitoring System Based on World Health Organization Guidelines 3Echo Therapeutics Receives Frost & Sullivan's 2011 Technology Innovation Award 2Echo Therapeutics Receives Frost & Sullivan's 2011 Technology Innovation Award 3Echo Therapeutics Receives Frost & Sullivan's 2011 Technology Innovation Award 4
(Date:9/16/2014)... Today The FSH Society, a world leader in ... Song,” featuring luminary pianist Steven Blier and two-time Grammy Award ... 2014 at the Tappan Hill Mansion, located on the former ... is proud to welcome Blier, who performs each year, and ... research. , FSHD, one of the most prevalent types of ...
(Date:9/16/2014)... Norfolk, VA (September 16, 2014) – ... desserts, announced today the launch of a limited edition ... October. In support of the American Cancer Society, an ... charitable donation in 2014 as well as help to ... among women in the United States. , The ...
(Date:9/16/2014)... 2014 (HealthDay News) -- Key connections between brain ... people with attention deficit hyperactivity disorder (ADHD), according ... within and between certain brain networks control ... the ability to focus on external tasks. This ... light on why those with ADHD are easily ...
(Date:9/16/2014)... 16, 2014 After working together for eight ... the premier fertility centers in the late 1990s and early ... to their hometown of New York City to launch Chelsea ... Genetics Labs. , Chelsea Fertility NYC offers full service ... in the New York Tri-State Area, and provides equal access ...
(Date:9/16/2014)... Dr. Randy Carlson and The Intentional Living ... Marriage event is coming to the Phoenix and Tucson ... better communicate, increase intimacy and have more fun with their ... and learning to strengthen your marriage and to rediscover intimacy,” ... Bible Church (Mesa), Saturday, Sept. 27 – Glendale Church of ...
Breaking Medicine News(10 mins):Health News:Pianist Steven Blier and Grammy Award-Winner Sylvia McNair to Perform Together for FSH Society Benefit 2Health News:Pianist Steven Blier and Grammy Award-Winner Sylvia McNair to Perform Together for FSH Society Benefit 3Health News:Lucy’s Joins Fight Against Breast Cancer With Launch Of Limited Edition Packaging And Charitable Donation 2Health News:Lucy’s Joins Fight Against Breast Cancer With Launch Of Limited Edition Packaging And Charitable Donation 3Health News:Study Sees Differences in Brain Connections of Kids With ADHD 2Health News:Chelsea Fertility NYC Offers New and Affordable Fertility Treatment Options for Patients in the New York Tri-State Area 2Health News:Chelsea Fertility NYC Offers New and Affordable Fertility Treatment Options for Patients in the New York Tri-State Area 3Health News:Chelsea Fertility NYC Offers New and Affordable Fertility Treatment Options for Patients in the New York Tri-State Area 4Health News:The Intentional Living Center Introduces the Love Your Marriage Night Featuring Dr. Randy Carlson in Arizona 2
... data is showing a dramatic,reduction in the accidental ... more on one group,s 20-year effort to protect ... from Safe Kids Worldwide at:, http://media.medialink.com/WebNR.aspx?story=35058 , ... and,photos for free and unrestricted use at ...
... Brown & Toland Medical Group,today announced a strong financial ... on total revenues of $235 million., The medical ... performance and other related bonuses from health plans. The,medical ... $8.2,million in bonus payments to eligible physicians. In 2007 ...
... seem to cause drop in heart rate variability, researchers ... of a small study show that the electromagnetic field ... babies, Italian researchers report. , Whether these changes in ... could have implications for premature infants who can spend ...
... the Only Treatment Approved to Both Reduce Exacerbations ... ... 30 The,U.S. Food and Drug Administration today approved Advair ... powder),for the reduction of exacerbations in patients with chronic obstructive,pulmonary ...
... better way to distinguish acute leukemia patients who require aggressive ... therapy for cure., The study is published in the May ... an accompanying editorial. , Researchers say that changes in levels ... the kinds and amount of proteins they make, might predict ...
... April 30 Allscripts, the leading,provider of clinical ... improve healthcare, today announced results for the three,months ... ), Total revenue for the three months ... $65.0 million for the same period last year,increasing ...
Cached Medicine News:Health News:Brown & Toland Announces 2007 Financial Results 2Health News:Incubators Affect Newborns' Heart Rates 2Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 2Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 3Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 4Health News:Molecular change may reveal risk of leukemia relapse 2Health News:Molecular change may reveal risk of leukemia relapse 3Health News:Allscripts Reports First Quarter 2008 Results 2Health News:Allscripts Reports First Quarter 2008 Results 3Health News:Allscripts Reports First Quarter 2008 Results 4Health News:Allscripts Reports First Quarter 2008 Results 5Health News:Allscripts Reports First Quarter 2008 Results 6Health News:Allscripts Reports First Quarter 2008 Results 7Health News:Allscripts Reports First Quarter 2008 Results 8Health News:Allscripts Reports First Quarter 2008 Results 9Health News:Allscripts Reports First Quarter 2008 Results 10
Inquire...
... Roches patented polymerase chain reaction (PCR) ... technology, is an essential component of Roches ... PCR allows minute amounts of selected unique ... into billions of copies (that is, to ...
... Introducing BenchMark XT® the only fully ... flexibility you need to expand your ... improve your slide turnaround time. All ... choose how to use the BenchMark ...
... Reicherts new ATP Auto Non-Contact Tonometer / ... / pachymeter, combining the measurement of IOP ... response to numerous clinical studies that have ... thickness as well as intraocular pressure in ...
Medicine Products: